Kadir M L, Islam M T, Hossain M M, Sultana S, Nasrin R, Hossain M M
Dr Md Lylatul Kadir, OSD, DGHS, Mohakhali, Dhaka, Bangladesh; Student MS Thesis Part, Department of Neurosurgery, Bangabandhu Sheikh Mujib Medical University (BSMMU), Shahbagh, Dhaka, Bangladesh.
Mymensingh Med J. 2017 Jul;26(3):642-649.
Post operative complications after pituitary tumour surgery vary according to procedure. There are several surgical procedures being done such as transcranial, transsphenoidal microsurgical and transsphenoidal endoscopic approaches. One of the commonest complications is diabetes insipidus (DI). Our main objective was to find out the incidence of diabetes insipidus in post operative period among patients undergoing surgical intervention for pituitary tumour in our institute. The presence of diabetes insipidus in the postoperative period was established by measuring serum Na+ concentration, hourly urine output and urinary specific gravity to find out the incidence of diabetes insipidus in postoperative period in relation to age, gender, tumour diameter, function of tumour (i.e., either hormone secreting or not) and operative procedure used for surgical resection of pituitary tumor. As it is the most common postoperative complication so, in this study we tried to find out how many of the patients develop diabetes insipidus in postoperative period following surgical resection of pituitary tumour. This cross sectional type of observational study was carried out in the department of Neurosurgery, BSMMU from May 2014 to October 2015 on 33 consecutive patients who underwent surgical intervention for pituitary tumour for the first time. Data was collected by using a data collection sheet. The incidence of diabetes insipidus was found 23.1% of patients in <30 year age group, 38.5% of patients in 31-40 year age group and 38.5% of patients in ≥40 year age group (p=0.764). In case of distribution of patients according to gender 38.5% of male and 61.5% of female developed diabetes insipidus (p=0.073). Regarding tumour size 30.8% and 69.2% of patients developed diabetes insipidus having tumour diameter <30mm and ≥30mm respectively (p=0.590). In case of operative procedure 69.2% of patients developed diabetes insipidus who was operated by transsphenoidal endoscopic approach, 23.1% and 7.7% of patients developed diabetes insipidus who underwent pituitary tumour resection through transsphenoidal microscopic approach and transcranial microscopic approach respectively (p=0.432). 17.6% of patients develop DI having functioning pituitary macroadenoma and 62.5% of patients develop DI having nonfunctioning pituitary macroadenoma. This observational study has been performed to find out the incidence of diabetes insipidus. Incidence of postoperative DI is more at or around the age of 40 years. It is slightly predominant in female. Most of the patients manifest DI in the first 24 hours of surgical intervention. Incidence of DI is low among patients having functioning pituitary macroadenoma.
垂体瘤手术后的并发症因手术方式而异。目前有多种手术方式,如经颅手术、经蝶窦显微手术和经蝶窦内镜手术。最常见的并发症之一是尿崩症(DI)。我们的主要目的是找出我院接受垂体瘤手术干预的患者术后尿崩症的发生率。通过测量血清钠浓度、每小时尿量和尿比重来确定术后尿崩症的存在,以了解术后尿崩症的发生率与年龄、性别、肿瘤直径、肿瘤功能(即是否分泌激素)以及用于垂体瘤手术切除的手术方式之间的关系。由于这是最常见的术后并发症,所以在本研究中我们试图找出垂体瘤手术切除后有多少患者在术后发生尿崩症。这项横断面观察性研究于2014年5月至2015年10月在孟加拉国谢赫穆吉布医学大学神经外科进行,研究对象为33例首次接受垂体瘤手术干预的连续患者。数据通过使用数据收集表收集。结果发现,年龄<30岁组患者中尿崩症的发生率为23.1%,31 - 40岁组患者中为38.5%,≥40岁组患者中为38.5%(p = 0.764)。按性别分布,男性患者中尿崩症的发生率为38.5%,女性患者中为61.5%(p = 0.073)。关于肿瘤大小,肿瘤直径<30mm和≥30mm的患者中尿崩症的发生率分别为30.8%和69.2%(p = 0.590)。在手术方式方面,经蝶窦内镜手术的患者中尿崩症的发生率为69.2%,经蝶窦显微手术和经颅显微手术切除垂体瘤的患者中尿崩症的发生率分别为23.1%和7.7%(p = 0.432)。有功能性垂体大腺瘤的患者中17.6%发生尿崩症,无功能性垂体大腺瘤的患者中62.5%发生尿崩症。进行这项观察性研究是为了找出尿崩症的发生率。术后尿崩症的发生率在40岁左右及以上更高。在女性中略为多见。大多数患者在手术干预后的头24小时内出现尿崩症。有功能性垂体大腺瘤的患者中尿崩症的发生率较低。